Antibodies against a protein found in neurons and in nerve supporting cells, may play a role in driving multiple…
Articles by Marisa Wexler, MS
Interactions between the body’s immune system and bacteria that live in the digestive tract — essentially, a person’s gut —…
Using an implantable scaffold to collect immune cells in mice, researchers have gained insights into the immunological mechanisms driving…
Navigating the uncertainty of living with relapsing-remitting multiple sclerosis (RRMS) brings a number of challenges, a study shows. That…
Children with multiple sclerosis (MS) who were exposed to sunlight for at least half an hour per day during…
Experts in Australia and New Zealand have published the first consensus guidelines for the care of adults with multiple…
The rate of relapses in children with pediatric-onset multiple sclerosis (POMS) tends to increase around the time that menstruation…
Smoking and obesity are both independently associated with faster disease progression in multiple sclerosis (MS), but when both risk…
A Phase 2 clinical trial is currently recruiting adults with relapsing types of multiple sclerosis (MS) to investigate…
Less frequent Ocrevus (ocrelizumab) infusions are as effective as standard dosing — when treatment is given typically every six…
Stem cell transplant can be considered a viable treatment option for people with relapsing-remitting multiple sclerosis (MS) who are…
The U.S. Food and Drug Administration (FDA) has added a new boxed warning to the prescribing information for glatiramer acetate,…
TG Therapeutics is working to develop a subcutaneous, or under-the-skin, version of Briumvi (ublituximab-xiiy), its approved therapy…
Cabaletta Bio is getting set to launch a clinical trial testing its cell therapy resecabtagene autoleucel (rese-cel) in people…
For women with multiple sclerosis (MS), disability starts to worsen significantly faster after menopause, according to a new study.
OCS-05, an experimental medication that Oculis is developing to treat acute optic neuritis, a common symptom of multiple…
IRX4204, a compound that Io Therapeutics is developing to treat neurological diseases, facilitated myelin repair and improved walking…
Treatment with Tecfidera (dimethyl fumarate) significantly reduces relapse rates for people with multiple sclerosis (MS), and most MS…
In the five years leading up to a multiple sclerosis (MS) diagnosis, children and adolescents often…
Most treatments for multiple sclerosis (MS) don’t increase the risk of major problems when used during pregnancy, an analysis…
The team at Multiple Sclerosis News Today has brought our audience the latest news about treatments, scientific research, and…
A specific type of brain lesion called a paramagnetic rim lesion, or PRL, is associated with worse disability over time…
Children with multiple sclerosis (MS) who come from poorer families or other disadvantageous circumstances tend to have more inflammation…
Higher cholesterol levels are associated with worse cognitive impairments in people with multiple sclerosis (MS), a study reported. The…
Adding noninvasive brain stimulation to physical therapy may help people with multiple sclerosis (MS) improve their balance and walking…
Fampyra (fampridine), an oral medication that’s approved to improve walking ability in adults with multiple sclerosis (MS), may…
Two enzymes in brain cells are responsible for mediating the toxic effects of certain fat molecules in multiple sclerosis…
A ketogenic diet — a very low-carbohydrate, high-fat eating plan called a keto diet for short — was able…
A mesenchymal stem cell therapy led to significant improvements in quality-of-life scores for people with multiple sclerosis (MS) in…
A new technology is designed to be a “wearable” device for neurons, wrapping around individual nerve fibers with a goal…